PMID: 8943748Oct 1, 1996Paper

Mycobacterium kansasii: its presentation, treatment and outcome in HIV infected patients

Journal of Clinical Pathology
G RooneyB Gazzard

Abstract

To report the clinical significance and treatment of Mycobacterium kansasii infection in the context of HIV disease. Retrospective case review of all isolates of M kansasii until June 1994. Ten cases of M kansasii were isolated. All but one patient with this infection had clinical symptoms compatible with generalised infection. The majority had chest infections with the organism isolated on induced sputum but not routine sputum. All isolates were sensitive to ethambutol and nine of 10 to rifampicin. All isolates were resistant to isoniazid and pyrazinamide. M kansasii is a pathogen in HIV infected patients and should be treated when isolated. Treatment should be with rifampicin and ethambutol but not isoniazid, as has been recommended previously.

References

Sep 15, 1991·Annals of Internal Medicine·G T Valainis
Sep 1, 1991·Reviews of Infectious Diseases·J L Carpenter, J M Parks
Jan 1, 1989·The American Review of Respiratory Disease·C R Horsburgh, R M Selik
Aug 1, 1986·Annals of Internal Medicine·C C HawkinsD Armstrong
Apr 1, 1986·British Journal of Diseases of the Chest·D E SchraufnagelB Pollak
Apr 1, 1972·The American Journal of Medicine·P F EngstromO N Barrett
Oct 1, 1982·The Journal of Antimicrobial Chemotherapy·G VinckéJ P Butzler
Sep 1, 1981·Reviews of Infectious Diseases·E Wolinsky
Mar 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D M BambergerL A Moore

❮ Previous
Next ❯

Citations

Aug 9, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jesús Canueto-QuinteroUNKNOWN Grupo Andaluz para el Estudio de las Esfermedades Infecciosas
Feb 23, 2007·AIDS·Patrick J LillieHiten K Thaker
Apr 11, 2008·Clinical Microbiology Reviews·L Beth Gadkowski, Jason E Stout
Jun 25, 2004·American Journal of Respiratory and Critical Care Medicine·Theodore K MarrasCharles L Daley
Jan 19, 1999·The Journal of Infection·J L KleinR J Coker
Jun 29, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Theodore K Marras, Charles L Daley
Sep 15, 2005·Journal of Medical Microbiology·Maria Alice da Silva TellesLee W Riley
Apr 13, 2005·The Journal of Antimicrobial Chemotherapy·Remedios GunaRafael Borrás

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
D M BambergerL A Moore
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
V PintadoA Guerrero
© 2021 Meta ULC. All rights reserved